Implantable Element Compounds for Immune Response Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implanted devices face challenges in modulating the immune response effectively, which affects their functionality and fidelity.
Innovation Solution
Development of compounds represented by Formula (I) and related compositions that can upregulate or downregulate the immune response, which are covalently attached to implantable elements to enhance their performance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If implanted devices are introduced to improve device function, then device functionality is enhanced, but immune response modulation becomes insufficient
Solution Approach 1:
The patent introduces compounds as intermediary substances that mediate between the implanted device and the immune system. These compounds are attached to device surfaces or released from device reservoirs to modulate immune responses, enabling the device to communicate with and influence biological environments without direct device-immune cell interaction.
Solution Approach 2:
The patent modifies device properties by changing chemical parameters through compound attachment or release. By altering surface chemistry, releasing different compound concentrations, or changing release kinetics, the device can dynamically adjust its immunomodulatory effects to achieve desired immune responses while maintaining device functionality.
2Adaptability or versatility
If device complexity is increased to achieve immune modulation, then immune response control improves, but device simplicity is reduced
Solution Approach 1:
The patent creates multi-functional compounds that can perform multiple immune modulation functions simultaneously. A single compound or coating formulation can address different immune cell types, regulate various immune pathways, and provide both anti-inflammatory and pro-healing effects, thereby achieving comprehensive immune control without requiring multiple separate device components.
Solution Approach 2:
The patent applies immunomodulatory compounds to device surfaces in advance during manufacturing or implantation. By pre-attaching compounds or pre-formulating release systems, the device is equipped with immune modulation capabilities before implantation, eliminating the need for complex post-implantation control mechanisms and simplifying the overall device structure.
Data Source
AI summary
The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and materials) comprising the same, as well as methods of use thereof, e.g., for treating or preventing a disease, disorder, or condition.